Polycythemia Vera (PV) Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting polycythemia vera (pv) clinical trials across 3 countries. Studies span Phase 2, Not Applicable, Phase 1, Phase 3. Top locations include New York, New York, United States, Charlotte, North Carolina, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Polycythemia Vera (PV) Trials at a Glance

7 actively recruiting trials for polycythemia vera (pv) are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in New York, Charlotte, and Chicago. Lead sponsors running polycythemia vera (pv) studies include Disc Medicine, Inc, Duan Minghui, and Chengdu Zenitar Biomedical Technology Co., Ltd.

Browse polycythemia vera (pv) trials by phase

Treatments under study

About Polycythemia Vera (PV) Clinical Trials

Looking for clinical trials for Polycythemia Vera (PV)? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Polycythemia Vera (PV) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Polycythemia Vera (PV) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Polycythemia Vera (PV)
Duan Minghui30 enrolled1 locationNCT07445893
Recruiting
Phase 1

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Primary myelofibrosis (PMF)Post-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+3 more
Prelude Therapeutics100 enrolled5 locationsNCT07469891
Recruiting
Phase 2

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Polycythemia Vera (PV)
Disc Medicine, Inc60 enrolled15 locationsNCT06985147
Recruiting
Phase 2

Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

Polycythemia Vera (PV)
Chengdu Zenitar Biomedical Technology Co., Ltd60 enrolled1 locationNCT07232290
Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Primary myelofibrosis (PMF)Myeloproliferative DisordersMyelofibrosis+49 more
MPN Research Foundation5,000 enrolled2 locationsNCT07362225
Recruiting
Phase 2

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Myelofibrosis (MF)Essential Thrombocythemia, ETPolycythemia Vera (PV)
Icahn School of Medicine at Mount Sinai54 enrolled1 locationNCT06541249
Recruiting
Phase 3

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

Polycythemia Vera (PV)
PharmaEssentia Japan K.K.67 enrolled6 locationsNCT04655092